NIAID Site Search

Jennifer M Ross, Ph.D., of the University of Washington K01 sample application

Last Reviewed: March 31, 2025

Lead Institution: Johns Hopkins University Research Areas The overall goals of the Southern Africa ICEMR are to study barriers to malaria control and elimination and inform national strategies. The Southern Africa ICEMR addresses these challenges in low, moderate, and high transmission settings in Zambia. In the low transmission setting in southern Zambia, ICEMR researchers study how malaria

Last Reviewed: July 12, 2024

This document provides an overview of Simulator GUI software including an explanation of various features and how to use them.

Last Reviewed: January 1, 2012

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

To accompany the annual small business parent notices of funding opportunities, NIH assembles a list of scientific priorities for small business awards of interest to its institutes and centers.

Published: August 2, 2023

A NIAID-supported Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic COVID-19 in adults has begun.

Published: July 27, 2020

NIAID Expert Panel provided addendum guidelines for the prevention of peanut allergy in the United States.

Last Reviewed: January 19, 2017

Last Reviewed: March 28, 2024

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

A fourth Phase 3 NIH clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers.

Published: September 23, 2020

A NIAID-supported Phase 3 clinical trial evaluating an investigational COVID-19 vaccine called AZD1222 will enroll around 30,000 adult volunteers.

Published: August 31, 2020

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018